Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies

Get started →

Sign up to stay up to date with the stocks you care about

Most recent public disclosures: AI-powered summaries of the latest corporate filings

10351

1

ASTROTECH Corp Astrotech Corporation Reports Significant Financial Challenges in Q3 2024

Via official filing (AI summary) | 8 months ago | 0 comments

10352

1

Vivani Medical, Inc. Vivani Medical Reports Improved Financials, Advances Clinical Programs for GLP-1 Implant Candidates

Via official filing (AI summary) | 8 months ago | 0 comments

10353

1

Greenpro Capital Corp. Greenpro Capital Corp. Reports Decline in Revenue and Assets, Losses, and Challenges

Via official filing (AI summary) | 8 months ago | 0 comments

10354

1

QT IMAGING HOLDINGS, INC. QT Imaging Reports Significant Revenue Growth, Net Loss in Latest Quarter

Via official filing (AI summary) | 8 months ago | 0 comments

10355

1

Urgent.ly Inc. Urgent.ly Reports 21% Revenue Decline, Net Loss Improvement in Q3 2024

Via official filing (AI summary) | 8 months ago | 0 comments

10356

1

Cocrystal Pharma, Inc. Cocrystal Pharma Reports Net Loss of $14.2M, Declines in Cash Position in Latest 10-Q Filing

Via official filing (AI summary) | 8 months ago | 0 comments

10357

1

CREATIVE REALITIES, INC. Creative Realities Reports 25% Revenue Growth, Improved Profitability in Q3 2024

Via official filing (AI summary) | 8 months ago | 0 comments

10358

1

BAIYU Holdings, Inc. BAIYU Holdings Reports Mixed Q3 Results, Net Income Recovery Amid Economic Challenges

Via official filing (AI summary) | 8 months ago | 0 comments

10359

1

Orgenesis Inc. Orgenesis Inc. Reports 215% Revenue Growth, Operating Loss in Q3 2024

Via official filing (AI summary) | 8 months ago | 0 comments

10360

1

Peraso Inc. Peraso Inc. Reports 11% Revenue Decline, Net Losses in Q3 2024

Via official filing (AI summary) | 8 months ago | 0 comments

10361

1

NU RIDE INC. Nu Ride Inc. Reports Improved Financials Following Bankruptcy Emergence, Net Income Turnaround

Via official filing (AI summary) | 8 months ago | 0 comments

10362

1

QXO, Inc. QXO, Inc. Reports Significant Financial Developments Following Strategic Changes and Investments

Via official filing (AI summary) | 8 months ago | 0 comments

10363

1

Global Gas Corp Global Gas Corporation Reports Mixed Financial Results, Net Income Recovery in Latest 10-Q Filing

Via official filing (AI summary) | 8 months ago | 0 comments

10364

1

Wilhelmina International, Inc. Wilhelmina International Reports Mixed Q3 Results, Net Income Up 28.6% for Nine Months

Via official filing (AI summary) | 8 months ago | 0 comments

10365

1

INTRUSION INC Intrusion Inc. Reports Mixed Revenue Performance, Improved Net Losses in Q3 2024

Via official filing (AI summary) | 8 months ago | 0 comments

10366

1

Verde Clean Fuels, Inc. Verde Clean Fuels Reports Operating Losses, Strategic Developments in Clean Fuels Technology Initiatives

Via official filing (AI summary) | 8 months ago | 0 comments

10367

1

Instil Bio, Inc. Instil Bio Reports Improved Financials, Reduced Operating Expenses, and Strategic Developments in Latest 10-Q Filing

Via official filing (AI summary) | 8 months ago | 0 comments

10368

1

Lexeo Therapeutics, Inc. Lexo Therapeutics Reports Financial Results, Advances Clinical Programs Amid Ongoing Losses

Via official filing (AI summary) | 8 months ago | 0 comments

10369

1

Marathon Bancorp, Inc. /MD/ Marathon Bancorp Reports 102.9% Increase in Net Income, Net Income of $174,907 in Q3 2024

Via official filing (AI summary) | 8 months ago | 0 comments

10370

1

Advanced Flower Capital Inc. Advanced Flower Capital Inc. Reports Decline in Revenue and Profitability in Latest Quarter

Via official filing (AI summary) | 8 months ago | 0 comments

10371

1

Grace Therapeutics, Inc. Grace Therapeutics Reports Financial Results, Focuses on Lead Drug Candidate GTx-104

Via official filing (AI summary) | 8 months ago | 0 comments

10372

1

Clene Inc. Clene Inc. Reports Mixed Financial Results for Q3 and Nine Months Ended September 30, 2024

Via official filing (AI summary) | 8 months ago | 0 comments

10373

1

Liquidia Corp Liquidia Corporation Reports 21% Q3 Revenue Growth, Significant Expenses Increase, and Strategic Developments

Via official filing (AI summary) | 8 months ago | 0 comments

10374

1

Aerkomm Inc. Aerkomm Inc. Reports Significant Revenue Decline, Net Loss in Latest Quarter

Via official filing (AI summary) | 8 months ago | 0 comments

10375

1

Passage BIO, Inc. Passage Bio Reports Improved Financials, Net Loss Reduction, and Strategic Developments in Q3 2024

Via official filing (AI summary) | 8 months ago | 0 comments